Daytime somnolence and night sleep disturbances in Parkinson's disease: background and future treatment prospective

被引：3

作者：

Antonini, A. ^{[1
]}

机构：

[1] Ist Clin Perfezionamento, Parkinson Inst Milan, Milan, Italy

来源：

NEUROLOGICAL SCIENCES | 2007年 / 28卷 / Suppl 1期

关键词：

Parkinson's disease; sleep abnormalities; daytime somnolence; dopaminergic treatment;

D O I：

10.1007/s10072-007-0732-1

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Sleep abnormalities are common in patients with Parkinson's disease (PD). Current clinical evidence suggests that both daytime somnolence and night-time sleep abnormalities are related mainly to worsening disease. Improvements in drug delivery, such as transdermal patch, allow more stable dopaminergic stimulation throughout the day. This approach might prove beneficial also for non-motor symptoms and particularly helpful in improving sleep architecture in PD.

引用

页码：S6 / S8

页数：3

共 14 条

[1]

Carbonari E, 2001, NEUROLOGY, V56, pA213

[2] The basis for day and night-time control symptoms of Parkinson's disease [J].

Chaudhuri, KR .

EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 :40-43

[3] Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole [J].

Frucht, S ;

Rogers, JD ;

Greene, PE ;

Gordon, MF ;

Fahn, S .

NEUROLOGY, 1999, 52 (09) :1908-1910

[4] The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease [J].

Högl, B ;

Rothdach, A ;

Wetter, TC ;

Trenkwalder, C .

NEUROPSYCHOPHARMACOLOGY, 2003, 28 (10) :1866-1870

[5] Sleep attacks in patients taking dopamine agonists: review [J].

Homann, CN ;

Wenzel, K ;

Suppan, K ;

Ivanic, G ;

Kriechbaum, N ;

Crevenna, R ;

Ott, E .

BMJ-BRITISH MEDICAL JOURNAL, 2002, 324 (7352) :1483-1487

[6]

Johnston Tom H, 2005, Expert Opin Drug Deliv, V2, P1059, DOI 10.1517/17425247.2.6.1059

[7] THE NIGHTTIME PROBLEMS OF PARKINSONS-DISEASE [J].

LEES, AJ ;

BLACKBURN, NA ;

CAMPBELL, VL .

CLINICAL NEUROPHARMACOLOGY, 1988, 11 (06) :512-519

[8] Sleep benefit in Parkinson's disease [J].

Merello, M ;

Hughes, A ;

Colosimo, C ;

Hoffman, M ;

Starkstein, S ;

Leiguarda, R .

MOVEMENT DISORDERS, 1997, 12 (04) :506-508

[9] Rotigotine for the treatment of Parkinson's disease [J].

Morgan, John C. ;

Sethi, Kapil D. .

EXPERT REVIEW OF NEUROTHERAPEUTICS, 2006, 6 (09) :1275-1282

[10] Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness [J].

Overeem, S ;

van Hilten, JJ ;

Ripley, B ;

Mignot, E ;

Nishino, S ;

Lammers, GJ .

NEUROLOGY, 2002, 58 (03) :498-499

← 1 2 →